Menu

HomeConferencesCollectionsCalls for PapersMSF Research EthicsAboutMy Saved Content
Logo

Science Portal

  • My Saved Content
  • Browse All
  • Conferences
  • Collections
  • Calls for Papers
  • MSF Research Ethics
  • Clinical Case Reporting
  • About
English
logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.6166.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.6166.produseast1
Journal Article
|Commentary

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Varaine FFV, Guglielmetti L, Mitnick CD
Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria | Journal Article / Commentary | MSF Science Portal
Similar Content
Loading...
Loading...
Loading...
Abstract

Countries

United States of America

Subject Area

tuberculosis

Languages

English
DOI
10.1164/rccm.201705-0988LE
Published Date
01 Dec 2017
PubMed ID
28715258
Journal
American Journal of Respiratory and Critical Care Medicine
Volume | Issue | Pages
Volume 196, Issue 11
Issue Date
2017-12-01
Dimensions Badge